The proposed project is a clinical intervention trial testing the feasibility and effectiveness of diabetic retinopathy screening evaluated by artificial intelligence (AI) based software in children with type 1 diabetes (CwD). Another novel method, the confocal microscopy of the retina will be used to assess the early stages of diabetic neuropathy. In parallel, we aim to assess the prevalence of diabetic retinopathy and neuropathy in a well-controlled population of CwD at a tertiary diabetes care center. Each participant will undergo an examination of diabetic retinopathy using the non-mydriatic fundus camera. The resulting photography will be evaluated by AI driven software. The participant will then follow this examinaton with fundus ophtalmoscopy in arteficial mydriasis as a standard method of diabetic retinopathy assessment. Another method, the optic coherence tomography (OCT), which is considered as the most sensitive method for diabetic retinopathy assessment, will be performed after that. The results of these methods will be compared to assess the sensitivity of each. The examination-satisfaction questionnaire will be given to the participants. In subjects over 18 years, a confocal microscopy of the retina examination will be performed to assess the status of the corneal sub-basal nerve plexus and the presence of diabetic neuropathy will be noted. The prevalence of diabetic retinopathy and neuropathy in this group of children with diabetes will be assessed based on the results.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
400
Non-mydriatic fundus camera photography assessed by artificial intelligence software
Fundus opthalmoscopy assessed by an experienced ophtalmologist
Optic coherence tomography assessed by an experienced ophtalmologist
In a subset of participants over 18 years of age, confocal microscopy of the retina will be performed to assess the presence of diabetic neuropathy
University Hospital Motol
Prague, Prague 5, Czechia
Feasibility of AI for retinopathy screening
The primary objective of this study is to test whether performing the diabetic retinopathy screening using the non-mydriatic fundus camera with AI software is feasible. The exact outcome is the percent of participants who will agree to undergo the procedure and will obtain a valid result (either positive or negative).
Time frame: Through study completion, on average 6 months.
Examination satisfaction
Participant and caregiver reported examination satisfaction assessed by a structured questionnaire on a Lickert scale from 1 to 5.
Time frame: Through study completion, on average 6 months.
Prevalence of diabetic retinopathy
Prevalence of diabetic retinopathy among CwD in a single center with favorable glucose control
Time frame: Through study completion, on average 6 months.
Prevalence of diabetic neuropathy
Prevalence of diabetic neuropathy in young people with diabetes (over 18 years) in a single center with favorable glucose control
Time frame: Through study completion, on average 6 months.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.